.webp)

Vaginal Rejuvenation in Mount Pleasant: IntimaLase vs O-Shot vs Surgical, and How to Decide
Ashley Harwyn, PA-C, ABAAHP | Published October 31, 2026 | Last updated October 31, 2026 | 14 min read
Three very different options, three very different evidence levels. A Mount Pleasant PA-C on what the research actually shows, and what to treat first.
This page is the neutral comparison for Mount Pleasant women weighing their options. We will walk through what each approach is, what the evidence genuinely shows, what the FDA has warned about, and the evidence-based treatments that should usually come first if you have a real medical condition. The goal is not to talk you into or out of anything. It is to make sure you choose with the facts, not a brochure.
- In 2018 the FDA warned against energy-based devices (laser and radiofrequency) marketed for vaginal “rejuvenation,” saying their safety and effectiveness for that use have not been established, and citing reports of burns, scarring, and painful sex.[1]
- In a double-blind, sham-controlled trial, fractional CO2 laser was no better than a fake procedure for postmenopausal vaginal symptoms at 12 months. Both groups improved, which is a strong hint that much of the benefit is placebo.[2]
- Evidence specific to IntimaLase (an Er:YAG laser) is preliminary and low-quality, with no sham-controlled trial confirming it works.[7]
- The O-Shot (platelet-rich plasma) is not FDA-approved for sexual function or incontinence, and the published evidence is a handful of mostly uncontrolled studies.[5]
- Surgery (labiaplasty, vaginoplasty) is the most invasive option and the only one that makes a true anatomical change, but ACOG notes most elective genital cosmetic surgery is not medically indicated and carries surgical risks.[4]
- If you have a real condition (menopausal dryness, stress incontinence, or lichen sclerosus), proven first-line treatments exist and should usually come first.[6]
What vaginal rejuvenation actually means
Here is the thing to understand before you compare anything: “vaginal rejuvenation” is a marketing umbrella, not a medical diagnosis.[4] It gets used for everything from menopausal dryness to mild urinary leakage to the appearance of the labia to a vague sense of laxity, and those are completely different issues with completely different answers. The single most useful step is to separate a treatable medical condition from an elective cosmetic goal, because the right path is not the same for the two.
The American College of Obstetricians and Gynecologists is direct about this: cosmetic vaginal procedures are often performed without a clear medical indication and without adequate data on safety or effectiveness, and patients deserve to be counseled on exactly that.[4] That is not a reason to feel ashamed of wanting to address a symptom that bothers you. It is a reason to insist on a real evaluation first, so you are treating the actual problem rather than paying for a procedure that may not do what the ad implies.
So the honest framing for the rest of this page is simple. If there is a diagnosable condition, it usually has a proven treatment that should come first. If it is genuinely elective, you are entitled to that choice, but you should make it knowing how thin the evidence is for some of these options.
Menopausal dryness, stress incontinence, and lichen sclerosus have proven first-line treatments (vaginal estrogen, pelvic floor therapy, prescription cream). Start there, after a real exam.
Energy devices are not FDA-cleared for this, a sham-controlled laser trial was negative, and PRP evidence is thin. Your choice, but make it with realistic expectations.
Laser and IntimaLase: what the evidence shows
Laser rejuvenation, including Fotona's IntimaLase (an Er:YAG laser) and fractional CO2 devices, is marketed to stimulate collagen in the vaginal wall and improve laxity, dryness, and mild leakage. The mechanism is plausible, which is exactly why the marketing is persuasive. But plausible is not the same as proven, and this is where the evidence gets uncomfortable for the industry.
Start with the FDA. In 2018 it issued a safety communication warning against energy-based devices marketed for vaginal rejuvenation, stating plainly that their safety and effectiveness for these uses have not been established, and noting reports of vaginal burns, scarring, and painful intercourse.[1] These lasers are FDA-cleared for certain gynecologic uses, such as destroying abnormal or precancerous tissue, but they are not cleared for “rejuvenation” or for treating menopause, incontinence, or sexual-function symptoms.[1] The agency went further and acted against device makers marketing these products deceptively for vaginal cosmetic uses.[3] That is a crucial distinction a sales page will blur.
Then there is the strongest piece of evidence: a rigorous trial. In a double-blind, randomized study, women with postmenopausal vaginal symptoms got either fractional CO2 laser or an identical-feeling sham procedure, and at 12 months the laser was not better than the sham.[2] Both groups improved, which tells you how powerful placebo and expectation are for these symptoms. Evidence specific to the Er:YAG IntimaLase device is thinner still, limited to small, often manufacturer-linked studies with no sham-controlled trial confirming it works.[7] None of this means a laser can never help anyone. It means the honest claim is “unproven,” and anyone promising guaranteed results is going well past the data.
Considering vaginal rejuvenation in Mount Pleasant? The honest first step is an exam, not a procedure, so you treat what is actually going on. See our options on the vaginal rejuvenation page, or call 843-981-0870 for a straight answer first.
The O-Shot and surgery: PRP and the anatomical option
The O-Shot takes platelet-rich plasma, concentrated from a sample of your own blood, and injects it into the clitoral and vaginal area, marketed to improve arousal, lubrication, and mild stress incontinence. Using your own platelets sounds elegant and low-risk, and the safety profile is reasonable. The problem is efficacy. A systematic review of PRP for female sexual dysfunction and stress incontinence found only a small number of studies, mostly uncontrolled, with the single randomized trial at high risk of bias, and concluded the overall evidence is low quality.[5] The O-Shot is also not FDA-approved for these uses. It may help some women, but that has not been demonstrated in good trials, and it should be offered with that honesty.
Surgery is a different category entirely. Labiaplasty reshapes the labia, and vaginoplasty tightens the vaginal canal, and unlike laser or PRP, these make a real anatomical change. That is the tradeoff: surgery is the most invasive option, with genuine recovery time and real risks including infection, altered sensation, painful sex, adhesions, and scarring, but it is the only one of the three that actually alters anatomy.[4] ACOG advises that most elective genital cosmetic surgery is not medically indicated, that the data on safety and effectiveness are limited, and that a good surgeon will explore your reasons and rule out an underlying condition before operating.[4] For the right person with clear expectations, it is a legitimate choice. It is not a casual one.
IntimaLase vs O-Shot vs surgical: how they compare
With the evidence laid out, the three options line up clearly on what matters: how invasive each is, how strong the evidence is, and what it realistically does. The table below compares them honestly, so you can see what you would actually be choosing.
| Option | How invasive | Evidence | Honest bottom line |
|---|---|---|---|
| Laser (IntimaLase, CO2) | Non-surgical, in-office | Not FDA-cleared for this; sham trial negative | Unproven for rejuvenation; realistic expectations only |
| O-Shot (PRP) | Injection, minimal downtime | Preliminary, mostly uncontrolled; not FDA-approved | Low-risk but unproven for sexual function |
| Surgery (labiaplasty, vaginoplasty) | Most invasive, real recovery | A true anatomical change; limited outcome data | Real change, real risk, not medically indicated for most |
Six things to weigh
Tick the ones that are true before you book anything. The more you can say yes to, the more informed your choice.
Read the table honestly and two things stand out. First, invasiveness and evidence do not line up the way you might hope: the least invasive options (laser, PRP) are also the least proven, while the most proven anatomical change comes from the most invasive option. Second, none of these is a first-line treatment for a medical problem. If your real issue is dryness, leakage, or a skin condition, the next section matters more than this table does, because there are treatments that actually have the evidence these do not.
Treat the real problem first: GSM, incontinence, and lichen sclerosus
This is the part a rejuvenation clinic has no incentive to tell you: many of the symptoms that send women looking for “rejuvenation” are real medical conditions with proven, often inexpensive first-line treatments. Treating the condition usually works better than treating the marketing category.
If your symptoms are vaginal dryness, burning, or pain from menopause, that is genitourinary syndrome of menopause, and low-dose vaginal estrogen is an effective, guideline-recommended treatment, with over-the-counter moisturizers and lubricants as first-line for milder cases.[6] It is well-studied, and our guide to vaginal estrogen safety covers the evidence, including for women worried about hormones. If your issue is leaking urine with a cough or sneeze, that is stress urinary incontinence, and the evidence-based first step is pelvic floor physical therapy, with pessaries and established surgical options available, none of which is a laser or an injection. And if you have chronic itching, whitening, or thinning of the vulvar skin, that can be lichen sclerosus, a condition that needs a prescription steroid and ongoing care, because untreated it carries a small cancer risk. These are not problems to laser or inject away. They are problems to diagnose and treat properly.
That is why a real evaluation comes first. The same examination that might lead to an elective procedure is the one that catches a condition you can actually treat, often more simply and effectively than any rejuvenation device.
How to decide in Mount Pleasant
If you are weighing these options in Mount Pleasant, the smartest first move is not choosing a procedure, it is getting an honest evaluation. A good clinic examines you, names what is actually going on, offers the evidence-based treatment if there is a diagnosable condition, and only then talks about elective options, with the real evidence on the table.
At Solcara, we offer both IntimaLase and the O-Shot, and we will tell you the truth about them: the evidence is limited, the FDA has not cleared energy devices for rejuvenation, and if you have a treatable condition, we start there. If you still want an elective option with realistic expectations fully explained, we will do it carefully and honestly. Our vaginal rejuvenation page lays out what we offer, and our guide to whether vaginal rejuvenation is right for you goes deeper on who it helps and who it does not. Call 843-981-0870 and we will give you a straight answer before you decide anything.
Is Vaginal Rejuvenation Right for You?
Who these procedures help, and who they do not. Read Is Vaginal Rejuvenation Right for You?.
Is Vaginal Estrogen Safe?
The evidence-based first-line for menopausal dryness. Read Is Vaginal Estrogen Safe?.
Vaginal Rejuvenation at Solcara
Our options, explained with honest expectations. Read Vaginal Rejuvenation at Solcara.
Ashley Harwyn, PA-C
PA-C, ABAAHP · Founder, Solcara Health
Online
Tap a question to ask
Get an honest evaluation first
An honest exam at our Mount Pleasant office or The Longevity Club downtown: we name what is actually going on, treat it with evidence, and discuss elective options only with the real facts.
BOOK A CONSULTATION →Or call 843-981-0870
Ashley Harwyn, PA-C, ABAAHP
Founder, Solcara Health · Diplomate, American Board of Anti-Aging Health Practitioners (ABAAHP)
Ashley has practiced medicine for more than fifteen years. Her path into it began at home, with a family member born with a congenital heart defect and a childhood spent watching how much the quality of a clinician's attention could change the shape of a life. She has since practiced across a range of settings, including medical mission work in Uganda, before founding Solcara to build the kind of practice she kept wishing existed, one that treats women as whole people and tells them the truth about what the evidence does and does not support.
Full bio →References
The FDA safety communication on energy-based devices, a sham-controlled JAMA trial of CO2 laser, the ACOG committee opinion on genital cosmetic surgery, a systematic review of PRP, and The Menopause Society GSM statement, each accessed October 1, 2026.
- U.S. Food and Drug Administration. FDA Warns Against Use of Energy-Based Devices to Perform Vaginal Rejuvenation or Vaginal Cosmetic Procedures: FDA Safety Communication. July 2018. fda.gov
- Li FG, Maheux-Lacroix S, Deans R, et al. Effect of Fractional Carbon Dioxide Laser vs Sham Treatment on Symptom Severity in Women With Postmenopausal Vaginal Symptoms: A Randomized Clinical Trial. JAMA. 2021. jamanetwork.com
- U.S. Food and Drug Administration. Statement on Efforts to Safeguard Women's Health from Deceptive Health Claims and Significant Risks Related to Devices Marketed for Vaginal Rejuvenation. July 2018. fda.gov
- American College of Obstetricians and Gynecologists. Elective Female Genital Cosmetic Surgery (Committee Opinion No. 795). 2020. acog.org
- Dankova I, Pyrgidis N, Tishukov M, et al. Efficacy and Safety of Platelet-Rich Plasma Injections for the Treatment of Female Sexual Dysfunction and Stress Urinary Incontinence: A Systematic Review. Biomedicines. 2023. mdpi.com
- The North American Menopause Society. The 2020 Genitourinary Syndrome of Menopause Position Statement of The North American Menopause Society. Menopause. 2020. isswsh.org
- Phillips C, Hillard T, Salvatore S, et al. Lasers for Genitourinary Syndrome of Menopause: What We Know and What We Need to Know. Climacteric. 2025. tandfonline.com
Medical Disclaimer: This article is for educational and informational purposes only and does not constitute medical advice. It describes a regulatory labeling change and general treatment categories; it is not a recommendation that any individual start, stop, or change a medication. Hormone therapy of any kind, including local vaginal estrogen, requires evaluation by a qualified, licensed clinician who knows your personal and family history. Consult a qualified healthcare provider before making medical decisions. Information reflects sources available as of October 1, 2026.
Ashley Harwyn, PA-C, ABAAHP, is a Diplomate of the American Board of Anti-Aging Health Practitioners (ABAAHP) through A4M and the founder of Solcara Health. Solcara serves South Carolina from Downtown Charleston (163 Rutledge Ave, Ste 202, The Longevity Club) and Mt. Pleasant (496 Bramson Ct, Ste 120).

Quick Links
